palmitoylethanolamide
Showing 1 - 25 of 51
Osteoarthritis, Knee Trial (palmitoylethanolamide, Placebo)
Not yet recruiting
- Osteoarthritis, Knee
- palmitoylethanolamide
- Placebo
- (no location specified)
Jan 31, 2023
Dyspepsia and Other Specified Disorders of Function of Stomach Trial in Leuven (Palmitoylethanolamide)
Recruiting
- Dyspepsia and Other Specified Disorders of Function of Stomach
- Palmitoylethanolamide
-
Leuven, Vlaams-Brabant, BelgiumKU Leuven
May 23, 2023
Irritable Bowel Syndrome Trial in Roma (palmithoylethanolamide/polydatin, )
Recruiting
- Irritable Bowel Syndrome
- palmithoylethanolamide/polydatin
- placebo
-
Roma, Rome, ItalyProf Giovanni Di Nardo
May 10, 2023
Bipolar Depression, MDD Trial in Chi?inau (Palmitoylethanolamide)
Recruiting
- Bipolar Depression
- Major Depressive Disorder
- Palmitoylethanolamide
-
Chișinău, Moldova, Republic ofState University of Medicine and Pharmacy " Nicolae Testemitsanu
Sep 26, 2023
Eczema, Atopic Trial in Brisbane (1.5% Palmitoylethanolamide (PEA) sold as Levagen+, Placebo Comparator)
Completed
- Eczema, Atopic
- 1.5% Palmitoylethanolamide (PEA) sold as Levagen+
- Placebo Comparator
-
Brisbane, Queensland, AustraliaRDC Global Pty Ltd
Aug 4, 2022
Opioid Use Disorder Trial in Boston (Palmitoylethanolamide, Placebo)
Not yet recruiting
- Opioid Use Disorder
- Palmitoylethanolamide
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 27, 2022
Muscle Recovery, Muscle Soreness Trial in Leuven (PEA, PLACEBO)
Recruiting
- Muscle Recovery
- Muscle Soreness
- PEA
- PLACEBO
-
Leuven, BelgiumExercise Physiology Research Group
Mar 1, 2023
Menstrual Pain Trial in New Farm (Levagen+, Microcrystalline cellulose)
Not yet recruiting
- Menstrual Pain
- Levagen+
- Microcrystalline cellulose
-
New Farm, Queensland, AustraliaRDC Clinical Pty Ltd
Apr 10, 2023
Tibial Fractures, Fibula Fracture, Knee Fracture Trial in Orange (Palmitoylethanolamide, Placebo)
Recruiting
- Tibial Fractures
- +2 more
- Palmitoylethanolamide
- Placebo
-
Orange, CaliforniaUC Irvine Medical Center
Mar 30, 2022
Oral-facial Pain Trial in Catania (Palmitoyletinolamide, Placebo)
Recruiting
- Oral-facial Pain
- Palmitoyletinolamide
- Placebo
-
Catania, ItalyAOU Policlinico G. Rodolico
May 23, 2023
Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)
Completed
- Diabetic Neuropathies
- +2 more
- Epineuron
- Placebo group
-
Thessaloníki, Thessaloniki, GreeceUniversity General Hospital AHEPA
Aug 8, 2023
Clinical High Risk for Psychosis, Ultra High Risk for Psychosis, Attenuated Psychotic Symptoms Trial in Udine (Ultra-micronized
Recruiting
- Clinical High Risk for Psychosis
- +2 more
- Ultra-micronized Palmitoylethanolamide (PEA)
-
Udine, UD, Italy
- +1 more
Sep 18, 2023
Chemo-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in United States
Recruiting
- Chemotherapy-Induced Peripheral Neuropathy
- +2 more
- Palmidrol
- +2 more
-
Middletown, Connecticut
- +8 more
Aug 16, 2022
Migraine Trial in Brisbane (Palmitoylethanolamide sold as Levagen +, Placebo comparator - maltodextrin and microcrystalline
Recruiting
- Migraine
- Palmitoylethanolamide sold as Levagen +
- Placebo comparator - maltodextrin and microcrystalline cellulose mix
-
Brisbane, Queensland, AustraliaRDC Global Pty Ltd
Dec 2, 2021
Fatigue, Cognitive Deficit, COVID-19 Trial in Vipiteno (palmitoylethanolamide co-ultramicronized with antioxidant flavonoid
Completed
- Fatigue
- +3 more
- palmitoylethanolamide co-ultramicronized with antioxidant flavonoid luteolin (PEA-LUT)
- Placebo
-
Vipiteno, BZ, ItalyHospital of Vipiteno-Sterzing
Apr 1, 2022
Covid19 Trial in Roma (Micronized and ultra-micronized Palmitoylethanolamide (mPEA and umPEA, 300mg + 600mg) oral suspension,
Completed
- Covid19
- Micronized and ultra-micronized Palmitoylethanolamide (mPEA and umPEA, 300mg + 600mg) oral suspension
- Standard Therapy
-
Roma, ItalyAnestesia e Rianimazione Azienda Ospedaliera Universitaria Sant'
Aug 24, 2021
Diabetic Peripheral Neuropathic Pain Trial in Southfield (CBD/PEA, Placebo)
Not yet recruiting
- Diabetic Peripheral Neuropathic Pain
- CBD/PEA
- Placebo
-
Southfield, MichiganPure Green Pharmaceuticals Inc.
Mar 2, 2023
Immunity Disorders Trial in Toronto (N-Acetyl-L-cysteine (NAC), Echinacea purpurea, Curcumin)
Completed
- Immunity Disorders
- N-Acetyl-L-cysteine (NAC)
- +3 more
-
Toronto, Ontario, CanadaDicentra
Feb 7, 2022
Tourette Syndrome Trial in New Haven (Dronabinol and Palmitoylethanolamide)
Completed
- Tourette Syndrome
- Dronabinol and Palmitoylethanolamide
-
New Haven, ConnecticutYale Child Study Center
Feb 10, 2020
Glaucoma Trial (palmitoylethanolamide (PEA) 600 mg)
Completed
- Glaucoma
- palmitoylethanolamide (PEA) 600 mg
- (no location specified)
Sep 10, 2019
Chronic Pain Trial in Milano (ultra-micronized palmitoylethanolamide, Placebo)
Completed
- Chronic Pain
- ultra-micronized palmitoylethanolamide
- Placebo
-
Milano, ItalyGeriatric Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore
Sep 10, 2019
Anosmia, Covid19, Hyposmia Trial in Roma (co-ultraPEALut, Olfactory Rehab)
Completed
- Anosmia
- +4 more
- co-ultraPEALut
- +3 more
-
Roma, ItalyMulticentric
Nov 12, 2022
Postprandial Inflammation Trial in Davis (Spermidine, Nicotinamide, PEA)
Completed
- Postprandial Inflammation
- Spermidine
- +4 more
-
Davis, CaliforniaUniversity of California Davis
Aug 17, 2021
Social Anxiety, Social Anxiety Disorder Trial in San Diego (Cannabidiol, Placebo)
Recruiting
- Social Anxiety
- Social Anxiety Disorder
- Cannabidiol
- Placebo
-
San Diego, CaliforniaUniversity of California, San Deigo
Apr 20, 2023